Anti-SPAG16 antibodies in primary progressive multiple sclerosis are associated with an elevated progression index. de Bock L, Fraussen J, Villar LM, Álvarez-Cermeño JC, Van Wijmeersch B, van Pesch V, Stinissen P, Somers V Eur J Neurol. 2015 Dec 26. PMID: 26706657. Abstract CommentRecommendBookmarkWatch